Actuate Therapeutics, Inc. · NASDAQ:ACTU

Actuate Therapeutics, Inc. financial statements

Actuate Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue0000
Research and development10.3M18.7M21.7M16.4M
Selling, general and administrative12.2M6.48M3.27M3.82M
Operating income-22.5M-25.2M-25.0M-20.2M
Depreciation and amortization25.2M25.0M20.2M
EBITDA0-10
Interest expense20.3K18.7K43.6K16.2K
Income before tax-22.2M-27.3M-24.7M-20.2M
Income tax8008000
Net income-22.2M-27.3M-24.7M-20.2M
Earnings per share, basic-1.06-3.26-17.24-1.34
Earnings per share, diluted-1.06-3.26-17.24

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents13.2M8.64M2.96M20.4M
Current assets13.6M9.21M3.00M20.5M
Total assets14.0M9.32M3.00M20.5M
Accounts payable1.52M1.92M3.42M2.13M
Current liabilities5.71M8.80M6.92M4.34M
Total debt405.0K405.0K405.0K
Total liabilities6.11M9.21M8.44M5.65M
Shareholders' equity7.92M104.2K-99.6M14.8M
Shares outstanding23.2M19.5M1.69M15.0M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-19.2M-21.8M-21.6M-17.8M
Capital spending0000
Free cash flow-19.2M-21.8M-21.6M-17.8M
Cash from financing23.7M27.5M4.13M19.3M
Share buybacks485.2K
Change in cash4.52M5.68M-17.5M1.46M